Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Adalimumab improved folliculitis decalvans in most patients.

Tofacitinib taken by mouth helps treat hair loss in children.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Dandelion-derived carbon dots effectively kill bacteria and speed up wound healing.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Bleomycin injections in mice cause skin thickening and hair loss.

Combining laser with PRP is more effective for vitiligo than PRP alone.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Tofacitinib effectively improves lichen planus pigmentosus symptoms.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Dock5 is important for skin healing and could help treat diabetic wounds.